FDA News: Week of January 23, 2017


Meet Stephen Ostroff, M.D., Acting FDA Commissioner 

Stephen Ostroff, M.D., Chief Scientist

Stephen Ostroff, M.D., is the acting Commissioner of Food and Drugs

Prior FDA Appointments

  •  Deputy Commissioner for Foods and Veterinary Medicine
  • Acting FDA Commissioner
  • Chief Scientist
  • Chief Medical Officer

Dr. Ostroff graduated from the University of Pennsylvania School of Medicine in 1981 and completed residencies in internal medicine at the University of Colorado Health Sciences Center and preventive medicine at CDC.

READ


benefit.JPG

2 comprehensive benefit-risk frameworks for Medical Devices and Drugs, respectively

Similarities:

  • Structured decision-support tools, quantitative and qualitative assessments
  • Consider nature and severity of the condition, magnitude of effect, strength of evidence, other available therapies, applicability ot broader population, postmarket data collection

Differences:

  • Ways in which uncertainty and patient perspectives are assessed

Considerations for Harmonized Framework:

  • Greater consistency in benefit/risk assessment
  • Reduce variability in decision making; promote transparent regulatory flexibility
  • Promote stakeholder understanding of FDA judgments based on scientific, clinical, and public health considerations
  • Foster increased alignment between FDA and external stakeholders

READ


FDA.JPG

READ


 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s